Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 19,590 shares at $50.62 ($992K) on 2016-11-10, disclosed to the SEC on 2016-11-14.
Open-market sale of $992k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.62 | 9,590 | $485K | 48.9% |
| 2 | $50.62 | 9,590 | $485K | 48.9% |
| 3 | $51.27 | 410 | $21K | 2.1% |
| Total | $50.63 avg | 19,590 | $992K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |